PD-1 Inhibits TCR Proximal Signaling By Sequestering SHP-2 Phosphatase and Facilitating Csk-Mediated Inhibitory Phosphorylation of Lck
Kankana Bardhan(Seres Therapeutics (United States)), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Duygu Sari(Sağlık Bilimleri Üniversitesi), Gordon J. Freeman(Dana-Farber Cancer Institute), Le‐Qun Li(Beth Israel Deaconess Medical Center), Nikolaos Patsoukis(Beth Israel Deaconess Medical Center), Theodore Anagnostou(Beth Israel Deaconess Medical Center), Pranam Chatterjee(ETH Zurich)
Cited by 7
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k